ロード中...
Treatment of diabetic peripheral neuropathy with engineered mesenchymal stromal cell-derived exosomes enriched with microRNA-146a provide amplified therapeutic efficacy
Diabetic peripheral neuropathy (DPN) is one of the most prevalent chronic complications of diabetes mellitus with no effective treatment. We recently demonstrated that mesenchymal stromal cell (MSC)-derived exosomes (exo-naïve) alleviate neurovascular dysfunction and improve functional recovery. Mic...
保存先:
| 出版年: | Exp Neurol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8169562/ https://ncbi.nlm.nih.gov/pubmed/33727097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2021.113694 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|